Key financial ranges
Market cap · USD equivalent
P/E ratio
Annual revenue · USD equivalent
Revenue growth
Valuation & profitability
Price / sales
Annual net income · USD equivalent
Net profit margin
Cash & debt
Cash · USD equivalent
Total debt · USD equivalent
Net cash · USD equivalent
Debt / revenue
| Company | Market cap | P/E | Revenue | Rev. growth | Net income | Cash | Debt | AI value |
|---|---|---|---|---|---|---|---|---|
| VRNOVerano Holdings Corp. | $1.57B | — | $821.5M | -6.5% | -$257.91M | $85.2M | $493.68M | Fair valued |
| FUNSix Flags Entertainment Corporation | $1.57B | — | $3.1B | +14.4% | -$1.6B | $134.53M | $4.99B | Fair valued |
| PAHCPhibro Animal Health Corp | $1.57B | 15.9× | $1.52B | +17.1% | $99.72M | $61.42M | $55.97M | Fair valued |
| ADIGAdi Global Distribution Inc. | $1.57B | — | — | — | — | $131M | $1.22B | Fair valued |
| LBRXLb Pharmaceuticals Inc | $1.57B | — | — | — | — | $283.11M | $5.22M | Overvalued |
| OMCLOmnicell, Inc. | $1.56B | 40.5× | $1.18B | +6.5% | $2.05M | $292.17M | $31.79M | Fair valued |
| SBHSally Beauty Holdings, Inc. | $1.56B | 8.6× | $3.7B | -0.4% | $195.88M | $173.1M | $1.51B | Undervalued |
| CPRICapri Holdings Ltd | $1.56B | 15.0× | $3.47B | -4.1% | $137M | $114M | $1.41B | Fair valued |
| ADNTAdient plc | $1.55B | 33.6× | $14.54B | -1.0% | -$281M | $924M | $2.65B | Undervalued |
| MLKNMillerknoll, Inc. | $1.55B | 17.2× | $3.84B | +4.7% | $91.5M | $167.7M | $1.81B | Fair valued |
| IMKTAIngles Markets Inc | $1.55B | 15.1× | $5.33B | -5.4% | $83.59M | $455.09M | $526.58M | Undervalued |
| RAREUltragenyx Pharmaceutical Inc. | $1.54B | — | $673M | +20.2% | -$575M | $125M | $36M | Fair valued |
| RVLVRevolve Group, Inc. | $1.54B | 21.5× | $1.23B | +8.5% | $61.71M | $311.57M | $30.87M | Fair valued |
| INVAInnoviva, Inc. | $1.54B | 5.2× | $411.33M | +14.7% | $271.17M | $570.39M | $269.66M | Undervalued |
| COURCoursera, Inc. | $1.53B | — | $757.5M | +9.0% | -$51M | $871.7M | $5.7M | Undervalued |
| BCAXBicara Therapeutics Inc. | $1.53B | — | — | — | — | $96.6M | $1.16M | Fair valued |
| XERSXeris Biopharma Holdings, Inc. | $1.53B | — | $291.85M | +43.7% | $554K | $121.75M | $289.44M | Fair valued |
| NATNORDIC AMERICAN TANKERS Ltd | $1.53B | 12.4× | $291.69M | -16.6% | $12.27M | $45.86M | $424.14M | Overvalued |
| YSWYYesway, Inc. | $1.52B | — | $2.67B | +5.8% | $54.02M | $81.61M | $728.41M | Fair valued |
| ARDTArdent Health, Inc. | $1.52B | 19.7× | $6.32B | +6.0% | $135.81M | $724.48M | $1.1B | Undervalued |